HC Wainwright Issues Pessimistic Forecast for OnKure Therapeutics (NASDAQ:OKUR) Stock Price
OnKure Therapeutics (NASDAQ:OKUR – Get Free Report) had its price objective decreased by HC Wainwright from $40.00 to $34.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. OKUR has been the subject of several other research reports. Leerink Partnrs upgraded shares of OnKure Therapeutics to a […]
OnKure Therapeutics (NASDAQ:OKUR – Get Free Report) had its price objective decreased by HC Wainwright from $40.00 to $34.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. OKUR has been the subject of several other research reports. Leerink Partnrs upgraded shares of OnKure Therapeutics to a […]
